{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:12:44Z","timestamp":1790374364123,"version":"4.1.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T00:00:00Z","timestamp":1766620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T00:00:00Z","timestamp":1766620800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100014803","name":"T\u00fcrk N\u00f6roloji Derne\u011fi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014803","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s10072-025-08724-4","type":"journal-article","created":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T12:13:41Z","timestamp":1766664821000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Detection of inflammation and glial cell-related biomarkers in adults with spinal muscular atrophy receiving nusinersen therapy"],"prefix":"10.1007","volume":"47","author":[{"given":"Doruk","family":"Arslan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeynep","family":"Ergul-Ulger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibel","family":"Goksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berin","family":"Inan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunes","family":"Esendagli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sevim","family":"Erdem-Ozdamar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ersin","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2355-6979","authenticated-orcid":false,"given":"Can Ebru","family":"Bekircan-Kurt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,25]]},"reference":[{"issue":"5","key":"8724_CR1","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1212\/con.0000000000000918","volume":"26","author":"JR Nance","year":"2020","unstructured":"Nance JR (2020) Spinal muscular atrophy. Continuum 26(5):1348\u20131368. https:\/\/doi.org\/10.1212\/con.0000000000000918","journal-title":"Continuum"},{"issue":"3","key":"8724_CR2","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1001\/archneur.1971.00490030102014","volume":"25","author":"G Werdnig","year":"1971","unstructured":"Werdnig G (1971) From the Pathological-Anatomical Institute of Graz TWO EARLY INFANTILE HEREDITARY CASES OF PROGRESSIVE MUSCULAR ATROPHY SIMULATING DYSTROPHY, BUT ON A NEURAL BASIS. Arch Neurol 25(3):276\u2013278. https:\/\/doi.org\/10.1001\/archneur.1971.00490030102014","journal-title":"Arch Neurol"},{"issue":"6266","key":"8724_CR3","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/344540a0","volume":"344","author":"LM Brzustowicz","year":"1990","unstructured":"Brzustowicz LM, Lehner T, Castilla LH, Penchaszadeh GK, Wilhelmsen KC et al (1990) Genetic mapping of chronic childhood-onset spinal muscular atrophy to chromosome 5q11.2-13.3. Nature 344(6266):540. https:\/\/doi.org\/10.1038\/344540a0","journal-title":"Nature"},{"issue":"2","key":"8724_CR4","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1086\/338627","volume":"70","author":"M Feldkotter","year":"2002","unstructured":"Feldkotter M, Schwarzer V, Wirth R, Wienker TF, Wirth B (2002) Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy. Am J Hum Genet 70(2):358\u2013368. https:\/\/doi.org\/10.1086\/338627","journal-title":"Am J Hum Genet"},{"issue":"5","key":"8724_CR5","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1056\/NEJMoa2102047","volume":"385","author":"BT Darras","year":"2021","unstructured":"Darras BT, Masson R, Mazurkiewicz-Be\u0142dzi\u0144ska M, Rose K, Xiong H et al (2021) Risdiplam-treated infants with type 1 spinal muscular atrophy versus historical controls. N Engl J Med 385(5):427\u2013435. https:\/\/doi.org\/10.1056\/NEJMoa2102047","journal-title":"N Engl J Med"},{"issue":"18","key":"8724_CR6","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1056\/NEJMoa1702752","volume":"377","author":"RS Finkel","year":"2017","unstructured":"Finkel RS, Mercuri E, Darras BT, Connolly AM, Kuntz NL et al (2017) Nusinersen versus sham control in infantile-onset spinal muscular atrophy. N Engl J Med 377(18):1723\u20131732. https:\/\/doi.org\/10.1056\/NEJMoa1702752","journal-title":"N Engl J Med"},{"issue":"18","key":"8724_CR7","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1056\/NEJMoa1706198","volume":"377","author":"JR Mendell","year":"2017","unstructured":"Mendell JR, Al-Zaidy S, Shell R, Arnold WD, Rodino-Klapac LR et al (2017) Single-dose gene-replacement therapy for spinal muscular atrophy. N Engl J Med 377(18):1713\u20131722. https:\/\/doi.org\/10.1056\/NEJMoa1706198","journal-title":"N Engl J Med"},{"key":"8724_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2019.00898","author":"DST Kariyawasam","year":"2019","unstructured":"Kariyawasam DST, D\u2019Silva A, Lin C, Ryan MM, Farrar MA (2019) Biomarkers and the development of a personalized medicine approach in spinal muscular atrophy. Front Neurol. https:\/\/doi.org\/10.3389\/fneur.2019.00898","journal-title":"Front Neurol"},{"key":"8724_CR9","doi-asserted-by":"publisher","first-page":"104870","DOI":"10.1016\/j.nbd.2020.104870","volume":"140","author":"E Abati","year":"2020","unstructured":"Abati E, Citterio G, Bresolin N, Comi GP, Corti S (2020) Glial cells involvement in spinal muscular atrophy: could SMA be a neuroinflammatory disease? Neurobiol Dis 140:104870. https:\/\/doi.org\/10.1016\/j.nbd.2020.104870","journal-title":"Neurobiol Dis"},{"issue":"5","key":"8724_CR10","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1002\/mus.25120","volume":"54","author":"S Dunaway Young","year":"2016","unstructured":"Dunaway Young S, Montes J, Kramer SS, Marra J, Salazar R et al (2016) Six-minute walk test is reliable and valid in spinal muscular atrophy. Muscle Nerve 54(5):836\u2013842. https:\/\/doi.org\/10.1002\/mus.25120","journal-title":"Muscle Nerve"},{"issue":"1","key":"8724_CR11","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","volume":"80","author":"S Lefebvre","year":"1995","unstructured":"Lefebvre S, B\u00fcrglen L, Reboullet S, Clermont O, Burlet P et al (1995) Identification and characterization of a spinal muscular atrophy-determining gene. Cell 80(1):155\u2013165. https:\/\/doi.org\/10.1016\/0092-8674(95)90460-3","journal-title":"Cell"},{"issue":"36","key":"8724_CR12","doi-asserted-by":"publisher","first-page":"12005","DOI":"10.1523\/jneurosci.2208-10.2010","volume":"30","author":"GH Park","year":"2010","unstructured":"Park GH, Maeno-Hikichi Y, Awano T, Landmesser LT, Monani UR (2010) Reduced survival of motor neuron (SMN) protein in motor neuronal progenitors functions cell autonomously to cause spinal muscular atrophy in model mice expressing the human centromeric (SMN2) gene. J Neurosci 30(36):12005\u201312019. https:\/\/doi.org\/10.1523\/jneurosci.2208-10.2010","journal-title":"J Neurosci"},{"issue":"33","key":"8724_CR13","doi-asserted-by":"publisher","first-page":"5010","DOI":"10.2174\/1381612823666170622095802","volume":"23","author":"M Pehar","year":"2017","unstructured":"Pehar M, Harlan BA, Killoy KM, Vargas MR (2017) Role and Therapeutic Potential of Astrocytes in Amyotrophic Lateral Sclerosis. Curr Pharm Des 23(33):5010\u20135021. https:\/\/doi.org\/10.2174\/1381612823666170622095802","journal-title":"Curr Pharm Des"},{"key":"8724_CR14","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.expneurol.2014.05.015","volume":"262","author":"T Philips","year":"2014","unstructured":"Philips T, Rothstein JD (2014) Glial cells in amyotrophic lateral sclerosis. Exp Neurol 262:111\u2013120. https:\/\/doi.org\/10.1016\/j.expneurol.2014.05.015","journal-title":"Exp Neurol"},{"issue":"5","key":"8724_CR15","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1136\/jnnp.2008.150698","volume":"80","author":"T Misu","year":"2009","unstructured":"Misu T, Takano R, Fujihara K, Takahashi T, Sato S et al (2009) Marked increase in cerebrospinal fluid glial fibrillar acidic protein in neuromyelitis optica: an astrocytic damage marker. J Neurol Neurosurg Psychiatry 80(5):575\u2013577. https:\/\/doi.org\/10.1136\/jnnp.2008.150698","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"8724_CR16","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s00401-003-0743-9","volume":"106","author":"S Araki","year":"2003","unstructured":"Araki S, Hayashi M, Tamagawa K, Saito M, Kato S et al (2003) Neuropathological analysis in spinal muscular atrophy type II. Acta Neuropathol 106(5):441\u2013448. https:\/\/doi.org\/10.1007\/s00401-003-0743-9","journal-title":"Acta Neuropathol"},{"issue":"3","key":"8724_CR17","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1097\/00005072-197107000-00005","volume":"30","author":"SM Chou","year":"1971","unstructured":"Chou SM, Fakadej AV (1971) Ultrastructure of chromatolytic motoneurons and anterior spinal roots in a case of Werdnig-Hoffmann disease. J Neuropathol Exp Neurol 30(3):368\u2013379. https:\/\/doi.org\/10.1097\/00005072-197107000-00005","journal-title":"J Neuropathol Exp Neurol"},{"issue":"14","key":"8724_CR18","doi-asserted-by":"publisher","first-page":"4094","DOI":"10.1093\/hmg\/ddv148","volume":"24","author":"H Rindt","year":"2015","unstructured":"Rindt H, Feng Z, Mazzasette C, Glascock JJ, Valdivia D et al (2015) Astrocytes influence the severity of spinal muscular atrophy. Hum Mol Genet 24(14):4094\u20134102. https:\/\/doi.org\/10.1093\/hmg\/ddv148","journal-title":"Hum Mol Genet"},{"issue":"9","key":"8724_CR19","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.18632\/aging.101551","volume":"10","author":"P Andr\u00e9s-Benito","year":"2018","unstructured":"Andr\u00e9s-Benito P, Dom\u00ednguez R, Colomina MJ, Llorens F, Povedano M et al (2018) YKL40 in sporadic amyotrophic lateral sclerosis: cerebrospinal fluid levels as a prognosis marker of disease progression. Aging (Albany NY) 10(9):2367\u20132382. https:\/\/doi.org\/10.18632\/aging.101551","journal-title":"Aging (Albany NY)"},{"issue":"12","key":"8724_CR20","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1136\/jnnp-2018-319586","volume":"90","author":"B Gille","year":"2019","unstructured":"Gille B, De Schaepdryver M, Dedeene L, Goossens J, Claeys KG et al (2019) Inflammatory markers in cerebrospinal fluid: independent prognostic biomarkers in amyotrophic lateral sclerosis? J Neurol Neurosurg Psychiatry 90(12):1338\u20131346. https:\/\/doi.org\/10.1136\/jnnp-2018-319586","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8724_CR21","doi-asserted-by":"publisher","first-page":"3023826","DOI":"10.1155\/2018\/3023826","volume":"2018","author":"MT Gonzalez-Garza","year":"2018","unstructured":"Gonzalez-Garza MT, Martinez HR, Cruz-Vega DE, Hernandez-Torre M, Moreno-Cuevas JE (2018) Adipsin, MIP-1b, and IL-8 as CSF biomarker panels for ALS diagnosis. Dis Markers 2018:3023826. https:\/\/doi.org\/10.1155\/2018\/3023826","journal-title":"Dis Markers"},{"key":"8724_CR22","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.cyto.2015.10.001","volume":"77","author":"K Kothur","year":"2016","unstructured":"Kothur K, Wienholt L, Brilot F, Dale RC (2016) CSF cytokines\/chemokines as biomarkers in neuroinflammatory CNS disorders: a systematic review. Cytokine 77:227\u2013237. https:\/\/doi.org\/10.1016\/j.cyto.2015.10.001","journal-title":"Cytokine"},{"key":"8724_CR23","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.mcn.2017.10.001","volume":"85","author":"C Sanfilippo","year":"2017","unstructured":"Sanfilippo C, Longo A, Lazzara F, Cambria D, Distefano G et al (2017) CHI3L1 and CHI3L2 overexpression in motor cortex and spinal cord of sALS patients. Mol Cell Neurosci 85:162\u2013169. https:\/\/doi.org\/10.1016\/j.mcn.2017.10.001","journal-title":"Mol Cell Neurosci"},{"issue":"11","key":"8724_CR24","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1136\/jnnp-2019-320442","volume":"90","author":"AG Thompson","year":"2019","unstructured":"Thompson AG, Gray E, Bampton A, Raciborska D, Talbot K et al (2019) CSF chitinase proteins in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 90(11):1215\u20131220. https:\/\/doi.org\/10.1136\/jnnp-2019-320442","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"8724_CR25","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1002\/glia.23768","volume":"68","author":"E Trias","year":"2020","unstructured":"Trias E, Kovacs M, King PH, Si Y, Kwon Y et al (2020) Schwann cells orchestrate peripheral nerve inflammation through the expression of CSF1, IL-34, and SCF in amyotrophic lateral sclerosis. Glia 68(6):1165\u20131181. https:\/\/doi.org\/10.1002\/glia.23768","journal-title":"Glia"},{"key":"8724_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci11030296","author":"LH M\u00fcschen","year":"2021","unstructured":"M\u00fcschen LH, Osmanovic A, Binz C, Jendretzky KF, Ranxha G et al (2021) Cerebrospinal fluid parameters in antisense oligonucleotide-treated adult 5q-spinal muscular atrophy patients. Brain Sci. https:\/\/doi.org\/10.3390\/brainsci11030296","journal-title":"Brain Sci"},{"key":"8724_CR27","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.3389\/fneur.2019.01179","volume":"10","author":"CD Wurster","year":"2019","unstructured":"Wurster CD, Koch JC, Cordts I, Dreyhaupt J, Otto M et al (2019) Routine Cerebrospinal Fluid (CSF) Parameters in Patients With Spinal Muscular Atrophy (SMA) Treated With Nusinersen. Front Neurol 10:1179. https:\/\/doi.org\/10.3389\/fneur.2019.01179","journal-title":"Front Neurol"},{"issue":"6","key":"8724_CR28","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.tins.2015.04.003","volume":"38","author":"Z Yang","year":"2015","unstructured":"Yang Z, Wang KK (2015) Glial fibrillary acidic protein: from intermediate filament assembly and gliosis to neurobiomarker. Trends Neurosci 38(6):364\u2013374. https:\/\/doi.org\/10.1016\/j.tins.2015.04.003","journal-title":"Trends Neurosci"},{"issue":"1","key":"8724_CR29","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1159\/000050753","volume":"46","author":"R Fukuyama","year":"2001","unstructured":"Fukuyama R, Izumoto T, Fushiki S (2001) The cerebrospinal fluid level of glial fibrillary acidic protein is increased in cerebrospinal fluid from Alzheimer\u2019s disease patients and correlates with severity of dementia. Eur Neurol 46(1):35\u201338. https:\/\/doi.org\/10.1159\/000050753","journal-title":"Eur Neurol"},{"issue":"3","key":"8724_CR30","doi-asserted-by":"publisher","first-page":"541","DOI":"10.3233\/jad-2009-1075","volume":"17","author":"S Jesse","year":"2009","unstructured":"Jesse S, Steinacker P, Cepek L, von Arnim CA, Tumani H et al (2009) Glial fibrillary acidic protein and protein S-100B: different concentration pattern of glial proteins in cerebrospinal fluid of patients with Alzheimer\u2019s disease and Creutzfeldt-Jakob disease. J Alzheimers Dis 17(3):541\u2013551. https:\/\/doi.org\/10.3233\/jad-2009-1075","journal-title":"J Alzheimers Dis"},{"issue":"9","key":"8724_CR31","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1007\/s00415-019-09389-8","volume":"266","author":"B Olsson","year":"2019","unstructured":"Olsson B, Alberg L, Cullen NC, Michael E, Wahlgren L et al (2019) NFL is a marker of treatment response in children with SMA treated with nusinersen. J Neurol 266(9):2129\u20132136. https:\/\/doi.org\/10.1007\/s00415-019-09389-8","journal-title":"J Neurol"},{"issue":"3","key":"8724_CR32","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.pneurobio.2008.09.006","volume":"86","author":"A Saavedra","year":"2008","unstructured":"Saavedra A, Baltazar G, Duarte EP (2008) Driving GDNF expression: the green and the red traffic lights. Prog Neurobiol 86(3):186\u2013215. https:\/\/doi.org\/10.1016\/j.pneurobio.2008.09.006","journal-title":"Prog Neurobiol"},{"issue":"5187","key":"8724_CR33","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1126\/science.7973664","volume":"266","author":"CE Henderson","year":"1994","unstructured":"Henderson CE, Phillips HS, Pollock RA, Davies AM, Lemeulle C et al (1994) GDNF: a potent survival factor for motoneurons present in peripheral nerve and muscle. Science 266(5187):1062\u20131064. https:\/\/doi.org\/10.1126\/science.7973664","journal-title":"Science"},{"issue":"2","key":"8724_CR34","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/s0304-3940(98)00434-0","volume":"250","author":"DC Lie","year":"1998","unstructured":"Lie DC, Weis J (1998) GDNF expression is increased in denervated human skeletal muscle. Neurosci Lett 250(2):87\u201390. https:\/\/doi.org\/10.1016\/s0304-3940(98)00434-0","journal-title":"Neurosci Lett"},{"issue":"8","key":"8724_CR35","doi-asserted-by":"publisher","first-page":"e689","DOI":"10.1371\/journal.pone.0000689","volume":"2","author":"M Suzuki","year":"2007","unstructured":"Suzuki M, McHugh J, Tork C, Shelley B, Klein SM et al (2007) GDNF secreting human neural progenitor cells protect dying motor neurons, but not their projection to muscle, in a rat model of familial ALS. PLoS ONE 2(8):e689. https:\/\/doi.org\/10.1371\/journal.pone.0000689","journal-title":"PLoS ONE"},{"issue":"6","key":"8724_CR36","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1023\/a:1020739831778","volume":"24","author":"M Yamamoto","year":"1999","unstructured":"Yamamoto M, Mitsuma N, Inukai A, Ito Y, Li M et al (1999) Expression of GDNF and GDNFR-alpha mRNAs in muscles of patients with motor neuron diseases. Neurochem Res 24(6):785\u2013790. https:\/\/doi.org\/10.1023\/a:1020739831778","journal-title":"Neurochem Res"},{"issue":"2","key":"8724_CR37","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.expneurol.2004.06.015","volume":"190","author":"Z Zhao","year":"2004","unstructured":"Zhao Z, Alam S, Oppenheim RW, Prevette DM, Evenson A et al (2004) Overexpression of glial cell line-derived neurotrophic factor in the CNS rescues motoneurons from programmed cell death and promotes their long-term survival following axotomy. Exp Neurol 190(2):356\u2013372. https:\/\/doi.org\/10.1016\/j.expneurol.2004.06.015","journal-title":"Exp Neurol"},{"issue":"3","key":"8724_CR38","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.pediatrneurol.2009.04.001","volume":"41","author":"A Chiaretti","year":"2009","unstructured":"Chiaretti A, Leoni C, Barone G, Genovese O, Brahe C et al (2009) Increased levels of glial cell-derived neurotrophic factor in CSF of infants with SMA. Pediatr Neurol 41(3):195\u2013199. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2009.04.001","journal-title":"Pediatr Neurol"},{"issue":"2","key":"8724_CR39","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S0169-328X(98)00017-5","volume":"55","author":"TCD Burazin","year":"1998","unstructured":"Burazin TCD, Gundlach AL (1998) Up-regulation of GDNFR-\u03b1 and c-ret mRNA in facial motor neurons following facial nerve injury in the rat. Mol Brain Res 55(2):331\u2013336. https:\/\/doi.org\/10.1016\/S0169-328X(98)00017-5","journal-title":"Mol Brain Res"},{"issue":"10","key":"8724_CR40","doi-asserted-by":"publisher","first-page":"3554","DOI":"10.1523\/jneurosci.17-10-03554.1997","volume":"17","author":"M Trupp","year":"1997","unstructured":"Trupp M, Belluardo N, Funakoshi H, Ib\u00e1\u00f1ez CF (1997) Complementary and overlapping expression of glial cell line-derived neurotrophic factor (GDNF), c-ret proto-oncogene, and GDNF receptor-alpha indicates multiple mechanisms of trophic actions in the adult rat CNS. J Neurosci 17(10):3554\u20133567. https:\/\/doi.org\/10.1523\/jneurosci.17-10-03554.1997","journal-title":"J Neurosci"},{"key":"8724_CR41","doi-asserted-by":"publisher","first-page":"982760","DOI":"10.3389\/fncel.2022.982760","volume":"16","author":"S Bonanno","year":"2022","unstructured":"Bonanno S, Cavalcante P, Salvi E, Giagnorio E, Malacarne C et al (2022) Identification of a cytokine profile in serum and cerebrospinal fluid of pediatric and adult spinal muscular atrophy patients and its modulation upon nusinersen treatment. Front Cell Neurosci 16:982760. https:\/\/doi.org\/10.3389\/fncel.2022.982760","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"8724_CR42","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s43856-023-00256-2","volume":"3","author":"T Nuzzo","year":"2023","unstructured":"Nuzzo T, Russo R, Errico F, D\u2019Amico A, Tewelde AG et al (2023) Nusinersen mitigates neuroinflammation in severe spinal muscular atrophy patients. Commun Med (Lond) 3(1):28. https:\/\/doi.org\/10.1038\/s43856-023-00256-2","journal-title":"Commun Med (Lond)"},{"key":"8724_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-017-0978-3","author":"CK Prajeeth","year":"2017","unstructured":"Prajeeth CK, Kronisch J, Khorooshi R, Knier B, Toft-hansen H et al (2017) Effectors of Th1 and Th17 cells act on astrocytes and augment their neuroinflammatory properties. J Neuroinflammation. https:\/\/doi.org\/10.1186\/s12974-017-0978-3","journal-title":"J Neuroinflammation"},{"issue":"9","key":"8724_CR44","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1038\/ni1496","volume":"8","author":"EV Acosta-Rodriguez","year":"2007","unstructured":"Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A, Sallusto F (2007) Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol 8(9):942\u2013949. https:\/\/doi.org\/10.1038\/ni1496","journal-title":"Nat Immunol"},{"issue":"2","key":"8724_CR45","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1002\/ana.25143","volume":"83","author":"AG Thompson","year":"2018","unstructured":"Thompson AG, Gray E, Th\u00e9z\u00e9nas ML, Charles PD, Evetts S et al (2018) Cerebrospinal fluid macrophage biomarkers in amyotrophic lateral sclerosis. Ann Neurol 83(2):258\u2013268. https:\/\/doi.org\/10.1002\/ana.25143","journal-title":"Ann Neurol"},{"issue":"4","key":"8724_CR46","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1111\/j.1750-3639.2011.00550.x","volume":"22","author":"D Bonneh-Barkay","year":"2012","unstructured":"Bonneh-Barkay D, Bissel SJ, Kofler J, Starkey A, Wang G et al (2012) Astrocyte and macrophage regulation of YKL-40 expression and cellular response in neuroinflammation. Brain Pathol 22(4):530\u2013546. https:\/\/doi.org\/10.1111\/j.1750-3639.2011.00550.x","journal-title":"Brain Pathol"},{"issue":"2","key":"8724_CR47","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1002\/acn3.283","volume":"3","author":"SJ Kolb","year":"2016","unstructured":"Kolb SJ, Coffey CS, Yankey JW, Krosschell K, Arnold WD et al (2016) Baseline results of the NeuroNEXT spinal muscular atrophy infant biomarker study. Ann Clin Transl Neurol 3(2):132\u2013145. https:\/\/doi.org\/10.1002\/acn3.283","journal-title":"Ann Clin Transl Neurol"},{"issue":"1","key":"8724_CR48","doi-asserted-by":"publisher","first-page":"14798","DOI":"10.1038\/s41598-018-33158-8","volume":"8","author":"A Abdelhak","year":"2018","unstructured":"Abdelhak A, Huss A, Kassubek J, Tumani H, Otto M (2018) Serum GFAP as a biomarker for disease severity in multiple sclerosis. Sci Rep 8(1):14798. https:\/\/doi.org\/10.1038\/s41598-018-33158-8","journal-title":"Sci Rep"},{"issue":"9","key":"8724_CR49","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/s1474-4422(18)30231-x","volume":"17","author":"JJ Bazarian","year":"2018","unstructured":"Bazarian JJ, Biberthaler P, Welch RD, Lewis LM, Barzo P et al (2018) Serum GFAP and UCH-L1 for prediction of absence of intracranial injuries on head CT (ALERT-TBI): a multicentre observational study. Lancet Neurol 17(9):782\u2013789. https:\/\/doi.org\/10.1016\/s1474-4422(18)30231-x","journal-title":"Lancet Neurol"},{"issue":"2","key":"8724_CR50","doi-asserted-by":"publisher","first-page":"481","DOI":"10.3233\/jad-180325","volume":"67","author":"P Oeckl","year":"2019","unstructured":"Oeckl P, Halbgebauer S, Anderl-Straub S, Steinacker P, Huss AM et al (2019) Glial fibrillary acidic protein in serum is increased in Alzheimer\u2019s disease and correlates with cognitive impairment. J Alzheimers Dis 67(2):481\u2013488. https:\/\/doi.org\/10.3233\/jad-180325","journal-title":"J Alzheimers Dis"},{"issue":"7","key":"8724_CR51","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1056\/NEJMoa1710504","volume":"378","author":"E Mercuri","year":"2018","unstructured":"Mercuri E, Darras BT, Chiriboga CA, Day JW, Campbell C et al (2018) Nusinersen versus sham control in later-onset spinal muscular atrophy. N Engl J Med 378(7):625\u2013635. https:\/\/doi.org\/10.1056\/NEJMoa1710504","journal-title":"N Engl J Med"},{"issue":"7","key":"8724_CR52","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1007\/s10072-023-06698-9","volume":"44","author":"D Arslan","year":"2023","unstructured":"Arslan D, Inan B, Kilinc M, Bekircan-Kurt CE, Erdem-Ozdamar S et al (2023) Nusinersen for adults with spinal muscular atrophy. Neurol Sci 44(7):2393\u20132400. https:\/\/doi.org\/10.1007\/s10072-023-06698-9","journal-title":"Neurol Sci"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-025-08724-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-025-08724-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-025-08724-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T08:12:21Z","timestamp":1770797541000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-025-08724-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,25]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["8724"],"URL":"https:\/\/doi.org\/10.1007\/s10072-025-08724-4","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,25]]},"assertion":[{"value":"17 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors hereby confirm that they have nothing to declare in respect of the following manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interest"}}],"article-number":"40"}}